Skip to main content

Free Content Increasing access to the MDR‐TB surveillance programme through a collaborative model in western Kenya*

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Abstract

Objective  Kenya, like many resource‐constrained countries, has a single mycobacterial laboratory, centrally located in Nairobi, with capacity for drug‐susceptibility testing (DST) – the gold standard in diagnosing drug‐resistant tuberculosis. We describe and evaluate a novel operational design that attempts to overcome diagnostic delivery barriers.

Methods  Review of the public DST programme identified several barriers limiting access: lack of programme awareness amongst physicians, limited supplies, unreliable transport and no specimen tracking methods. Staff visited 19 clinic sites in western Kenya and trained healthcare providers in regard to the novel diagnostics model. Provincial laboratory registries were reviewed to assess utilization of DST services prior to and after programme modification.

Results  Onsite training consisted of the inclusion criteria for re‐treatment patients – the high‐priority group for DST. Additionally, infrastructural support established a stable supply chain. An existing transport system was adapted to deliver sputum specimens. Task shifting created an accession and tracking system of specimens. During the 24 months post‐implementation, the number of re‐treatment specimens from the catchment area increased from 9.1 to 23.5 specimens per month. In comparing annual data pre‐ and post‐implementation, the proportion of re‐treatment cases receiving DST increased from 24.7% (n = 403) to 32.5% (n = 574) (P < 0.001), and the number of multidrug‐resistant (MDR) TB cases increased from 5 to 10 cases.

Conclusion  The delivery model significantly increased the proportion of re‐treatment cases receiving DST. Barriers to accessing the national MDR‐TB surveillance programme can be overcome through an operational model based on pragmatic use of existing services from multiple partners.

Language: English

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1365-3156.2011.02933.x

Affiliations: 1:  Duke University Medical Center, Durham, NC, USA 2:  Moi University School of Medicine, Eldoret, Kenya 3:  Warren Alpert Medical School of Brown University, Providence, RI, USA 4:  Division of Leprosy, Tuberculosis, and Lung Disease, Nairobi, Kenya

Publication date: 2012-03-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more